Afamelanotide as Adjunctive Therapy in Patients Undergoing Photodynamic Therapy (PDT) Utilising Porfimer Sodium
Status:
Completed
Trial end date:
2009-05-28
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety and efficacy of afamelanotide
(previously developed as CUV1647) as adjunctive therapy in patients undergoing photodynamic
therapy using porfimer sodium.